Immunosuppressants are class of drugs that are used to curtail the receptors body’s ability to reject the organ to be transplanted. Some typically used immunosuppressant drugs include; Calcineurin Inhibitors (Tacrolimus and Cyclosporine, Antiproliferative agents), (Mycophenolate Mofetil, Mycophenolate Sodium and Azathioprine), mTOR inhibitor (Sirolimus) and Steroids (Prednisone). Intake of immunosuppressants is very essential for the receptor of the organs as directed. Global Solid Organ Transplant Immunosuppressant Market was valued at just under USD 3,750 million in 2019 and is expected to reach over USD 7,050 million in 2027, growing at a CAGR of over 12.5% during the forecast period.
By type, global Solid Organ Transplant Immunosuppressant market is segmented into Monoclonal Antibodies, Corticosteroids, mTOR Inhibitors, Calcineurin Inhibitors, Others. In 2019, global Solid Organ Transplant Immunosuppressant market was dominated by Monoclonal Antibodies segment with over 25% share in total revenue generation. It is also expected to be one of the fastest growing segments over the forecast period and maintain its dominance. Monoclonal antibodies (mAbs) are well-established therapeutics, as evidenced by the large number of Food and Drug Administrationapproved mAbs for the treatment of cancers, and inflammatory or autoimmune diseases, and for the prevention and treatment of solid organ transplant rejection.
Download FREE Sample PDF of Global Solid Organ Transplant Immunosuppressant Market: https://www.eonmarketresearch.com/sample/76629
Global Solid Organ Transplant Immunosuppressant market is segmented on the basis of applications such as Preoperative Solid Organ Transplant Immunosuppressant, Surgery Solid Organ Transplant Immunosuppressant and Postoperative Solid Organ Transplant Immunosuppressant. Postoperative Solid Organ Transplant Immunosuppressant segment dominated the global Solid Organ Transplant Immunosuppressant market with over 40% share in 2019. Preoperative Solid Organ Transplant Immunosuppressant segment also accounted for significant share in 2019.
North America dominated the global Solid Organ Transplant Immunosuppressant market in 2019 with over 40% share in total revenue generated by this industry. North America is closely followed by the Europe. North America dominated the global organ transplant industry with highest number of transplantations occurring per annum. However, with growing spending power on healthcare and increasing awareness among donors, is driving growth of organ transplantation in Asia Pacific at rapid pace, which in turn driving demand for Solid Organ Transplant Immunosuppressants.
Major players in global Solid Organ Transplant Immunosuppressant market include but not limited to Huadong Pharmaceutical, North China Pharmaceutical Huasheng Co., Sinopharm Chuan Kang Pharmaceutical, Hisun, Sl Pharm, Nanjing Hicin, Hongsheng, Cinkate Corporation, Wnsui, Huitian and others. The global Solid Organ Transplant Immunosuppressant market is highly concentrated with top six players accounting for just over 45% share in the global market.
Buy This Premium Report: https://www.eonmarketresearch.com/buy/76629
Segmentation:
Solid Organ Transplant Immunosuppressant Market by Type, 2015 – 2027 Volume (Tons) and Revenue (USD Million)
- Monoclonal Antibodies
- Corticosteroids
- mTOR Inhibitors
- Calcineurin Inhibitors
- Others
Solid Organ Transplant Immunosuppressant Market by Application, 2015 – 2027 Volume (Tons) and Revenue (USD Million)
- Preoperative Solid Organ Transplant Immunosuppressant
- Surgery Solid Organ Transplant Immunosuppressant
- Postoperative Solid Organ Transplant Immunosuppressant
Solid Organ Transplant Immunosuppressant Market by Region, 2015 – 2027 Volume (Tons) and Revenue (USD Million)
North America
- United States
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Russia
- Italy
- Spain
Asia Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Australia
Latin America
- Brazil
- Argentina
- Chile
- Peru
Middle East and Africa
- Egypt
- Saudi Arabia
- South Africa
- Turkey
- Israel
Do Inquiry Before Purchasing Report Here and Ask For Discount: https://www.eonmarketresearch.com/enquiry/76629
Solid Organ Transplant Immunosuppressant Market by Company, 2018 – 2019 Volume (Tons) and Revenue (USD Million)
- Huadong Pharmaceutical
- North China Pharmaceutical Huasheng Co.
- Sinopharm Chuan Kang Pharmaceutical
- Hisun
- Sl Pharm
- Nanjing Hicin
- Hongsheng
- Cinkate Corporation
- Wnsui
- Huitian
Explore Related Reports:
- Global Ganciclovir Market
- Global Kifunensine Market
- Global Trazodone Hydrochloride (API) Market
- Global Primary Hyperoxaluria Drug Market
- Global Cerebroprotein Hydrolysate Market
- Global Caries Detection Devices Market
About Us:
Eon Market Research (EMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers.
Contact Us:
Eon Market Research
Phone: +1 703 879 7090
Email: sales@eonmarketresearch.com
